Welcome to our dedicated page for The Timken Company news (Ticker: $TKR), a resource for investors and traders seeking the latest updates and insights on The Timken Company stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect The Timken Company's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of The Timken Company's position in the market.
The Timken Company (TKR) announced a 3% increase in its quarterly dividend to 34 cents per share. This marks 11 consecutive years of dividend increases, reflecting confidence in the company's long-term growth strategy and financial performance. Timken has a long history of dividend payments, with 408 consecutive quarters of dividends paid since 1922. The company's commitment to consistent dividend growth aligns with its capital allocation strategy.
Timken Company reported first-quarter 2024 sales of $1.19 billion, down 5.7% from last year. Despite lower revenue, earnings per share were $1.46 and adjusted EPS $1.77. Full-year outlook raised with expected EPS of $5.10-$5.40 and adjusted EPS $6.00-$6.30. Solid margin performance in the quarter. CEO succession plan announced. Timken recognized for ethics and innovation.
